HI
PTCT icon

Harbour Investments’s PTC Therapeutics PTCT Stock Holding History

Harbour Investments’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.57K Buy
56
+21
+60% +$1.52K ﹤0.01% 3721
2026
Q1 		$2.38K Hold
35
– – ﹤0.01% 3863
2025
Q4 		$2.66K Hold
35
– – ﹤0.01% 3232
2025
Q3 		$2.15K Hold
35
– – ﹤0.01% 3246
2025
Q2 		$1.71K Hold
35
– – ﹤0.01% 3173
2025
Q1 		$1.78K Hold
35
– – ﹤0.01% 3112
2024
Q4 		$1.58K Hold
35
– – ﹤0.01% 3064
2024
Q3 		$1.3K Buy
+35
New +$1.17K ﹤0.01% 3039

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Harbour Investments's PTCT Position: Q2 2026 in Review

Harbour Investments increased its PTC Therapeutics (PTCT) stake by 60% in Q2 2026, buying an estimated $1.52K and bringing the position to 56 shares worth $4.57K. The position accounts for ﹤0.01% of the portfolio, ranked #3721.

Harbour Investments first reported a position in PTCT in Q3 2024 and has held it in 8 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Harbour Investments held 56 shares of PTC Therapeutics worth $4.57K as of Q2 2026.
  • Harbour Investments bought 21 PTC Therapeutics shares in Q2 2026, an estimated $1.52K.
  • PTC Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3721 holding.
  • Harbour Investments first reported a position in PTC Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.